OrbiMed Capital GP IX LLC is Director at Shattuck Labs, Inc. (STTK). They have made 1 open-market trade across 1 company since 2025, most recently 2025-08-25.
CIK 0001920574
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $5.5M since 2025, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| STTK | 1,051,021 | $5.7M |
Shares reported on the most recent Form 4, priced at the 2025-09-02 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| STTK | BUY | 2025-08-25 | 2025-09-02 | $0.87 | $5.5M | +79.4% | +121.5% | +125.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.